<--- Back to Details
First PageDocument Content
Osteopathies / Bone fractures / Osteoporosis / Alendronic acid / Osteopenia / Bone density / Compression fracture / Raloxifene / Hip fracture / Medicine / Bisphosphonates / Health
Date: 2009-04-27 08:41:36
Osteopathies
Bone fractures
Osteoporosis
Alendronic acid
Osteopenia
Bone density
Compression fracture
Raloxifene
Hip fracture
Medicine
Bisphosphonates
Health

Add to Reading List

Source URL: images.the-scientist.com

Download Document from Source Website

File Size: 2,53 MB

Share Document on Facebook

Similar Documents

Preventing Falls * Persons with developmental disabilities may be at increased risk for falls due to things such as cerebral palsy, osteoporosis, epilepsy and some medications.

DocID: 1vgLN - View Document

NEWS RELEASE NEWS RELEASE NEWS RELEASE NEWS RELEASE NEWS RELEASE Contact: (SUNSWEET GROWERS TO RETURN AS OFFICIAL SPONSOR OF WORLD OSTEOPOROSIS DAY Sunsweet Promotes the Positive Role o

DocID: 1vd0S - View Document

Master’s Thesis Proposal Damage Morphology in Compact Bone Associated with Distinct Loading Modes Background An annual prevalence of 1.6 million osteoporosis related hip fractures, constitutes a major sociomedical cha

DocID: 1v0QH - View Document

Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses Newmg/day Minivelle,

DocID: 1ufoU - View Document

New Minivelle® (Estradiol Transdermal Systemmg/day Dose Now Available by Prescription in U.S. Pharmacies New dose approved by FDA for the prevention of postmenopausal osteoporosis only; higher doses of Minivelle

DocID: 1u26h - View Document